Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma

Clinical trial NCT00577629 · COMPLETED

Trial details

NCT number: NCT00577629
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2005-06-18
Primary completion: 2012-04-08
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.